Clinical Trials: An Exploratory Clinical Trial of Zoledronic Acid in Women With CIN 2/3 or 3

Sponsor and Collaborators

University of California, San Francisco

National Cancer Institute (NCI)

Contact

Clinical Trials Office, UCSF Helen Diller Family Comprehensive Cancer Center

877-827-3222        

Principal Investigator

Karen Smith-McCune, MD, PhD, University of California, San Francisco

ClinicalTrials.gov Identifier

NCT00278434

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs